Archive for February 2010
European Counterfeit Drug Market Worth more than $14 Billion
At the Partnership for Safe Medicines (PSM), we've long cautioned consumers about the dangers of counterfeit drugs—a growing issue affecting all corners of the globe. Now, the Pfizer-commissioned study, "Cracking Counterfeit Europe," has estimated that the counterfeit medicines market in Europe is worth more than $14 billion. The investigation, which covered 14 European countries, comes…
[...]Partnership for Safe Medicines Applauds Google’s Updated U.S. Pharmaceutical Advertising Policy
WASHINGTON, DC – Feb. 10, 2010 – The Partnership for Safe Medicines (PSM) today commended Google for its updated policy on U.S. pharmaceutical advertising through its paid search program, AdWords. Toward the end of the month, Google will refine its advertising model to accept ads only from online pharmacies in the U.S. that are accredited…
[...]$12M in Counterfeit Drugs Seized in Southeast Asia
View larger map An international police operation led to the seizure of $20M in counterfeit and illegal medicines, including antibiotics, anitimalarials, contraceptives, anti-tetanus vaccines, aspirin and drugs to treat erectile dysfunction. An estimated $12M were counterfeits with the remaining $8M found to be drugs that were “expired, diverted or unregistered.” Who: Medical Products Counterfeiting and…
[...]Twohig M, Skilton SJ, Fujimoto G, Ellor N, Plumb RS. Rapid detection and identification of counterfeit of adulterated products of synthetic phosphodiesterase type-5 inhibitors with an atmospheric solids analysis probe. Drug Test Anal. 2010;2(2):45-50.
The market success of the three approved synthetic phosphodiesterase type-5 (PDE-5) inhibitors for the treatment of erectile dysfunction has led to an explosion in counterfeit versions of these drugs. In parallel a large market has developed for herbal products claimed to be natural alternatives to these synthetic drugs. The herbal products are heavily advertised on…
[...]